Katie Kim

Katie Kim, Ph.D., is a Director in Technical Services Manufacturing Science (TS/MS) at Eli Lilly and Company. With over nine years of experience spanning research and technical leadership, Katie is responsible for developing and implementing strategies that ensure robust manufacturing processes to achieve consistent product quality. She has lead strategy design and development for new manufacturing sites, lines, and processes, with a focus on aseptic manufacturing of parenteral products spanning several delivery systems and dosage forms. Her expertise includes process optimization, technical stewardship, and cross-functional collaboration to deliver reliable drug products that meet label claims. Katie earned her Ph.D. in Chemistry from Duke University, where she focused on chemical probe design and synthesis, and advanced analytical techniques. She has experience publishing in prominent journals and has received recognition for scientific excellence. At Lilly, Katie leads initiatives that bridge science and operations to support patient-centric outcomes across injectable platforms and actively shapes industry best practices for controlling drug product content and uniformity.